Open AccessFracture risk following intermission of osteoporosis therapy
Author(s) -
Elaine Dennison,
Cyrus Cooper,
J. A. Kanis,
Olivier Bruyère,
Stuart Silverman,
Eugene McCloskey,
Bo Abrahamsen,
Daniel PrietoAlhambra,
Serge Ferrari
Publication year - 2019
Publication title -
osteoporosis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 170
eISSN - 1433-2965
pISSN - 0937-941X
DOI - 10.1007/s00198-019-05002-w
Subject(s) - denosumab , medicine , discontinuation , osteoporosis , adverse effect , teriparatide , drug holiday , osteonecrosis of the jaw , surgery , intensive care medicine , bisphosphonate , bone mineral , family medicine , human immunodeficiency virus (hiv)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom